Hos D - Search Results

1

Impact of early intensified postoperative corticosteroids on immune reaction rates after Descemet membrane endothelial keratoplasty (DMEK).

Schaub F, Mestanoglu M, Cursiefen C, Hos D. Schaub F, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):693-695. doi: 10.1007/s00417-021-05393-9. Epub 2021 Sep 1. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34468833 Free PMC article. No abstract available.

2

Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.

Hos D, Bock F, Dietrich T, Onderka J, Kruse FE, Thierauch KH, Cursiefen C. Hos D, et al. Invest Ophthalmol Vis Sci. 2008 May;49(5):1836-42. doi: 10.1167/iovs.07-1314. Invest Ophthalmol Vis Sci. 2008. PMID: 18436817

3

Age-related changes in murine limbal lymphatic vessels and corneal lymphangiogenesis.

Hos D, Bachmann B, Bock F, Onderka J, Cursiefen C. Hos D, et al. Exp Eye Res. 2008 Nov;87(5):427-32. doi: 10.1016/j.exer.2008.07.013. Epub 2008 Aug 8. Exp Eye Res. 2008. PMID: 18755186

4

Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts.

Bock F, Onderka J, Hos D, Horn F, Martus P, Cursiefen C. Bock F, et al. Among authors: hos d. Exp Eye Res. 2008 Nov;87(5):462-70. doi: 10.1016/j.exer.2008.08.007. Epub 2008 Aug 26. Exp Eye Res. 2008. PMID: 18789928

5

Transient postoperative vascular endothelial growth factor (VEGF)-neutralisation improves graft survival in corneas with partly regressed inflammatory neovascularisation.

Bachmann BO, Luetjen-Drecoll E, Bock F, Wiegand SJ, Hos D, Dana R, Kruse FE, Cursiefen C. Bachmann BO, et al. Among authors: hos d. Br J Ophthalmol. 2009 Aug;93(8):1075-80. doi: 10.1136/bjo.2008.145128. Epub 2009 Feb 17. Br J Ophthalmol. 2009. PMID: 19224901

6

Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.

Dietrich T, Bock F, Yuen D, Hos D, Bachmann BO, Zahn G, Wiegand S, Chen L, Cursiefen C. Dietrich T, et al. Among authors: hos d. J Immunol. 2010 Jan 15;184(2):535-9. doi: 10.4049/jimmunol.0903180. Epub 2009 Dec 16. J Immunol. 2010. PMID: 20018627 Free PMC article.

7

Genetic heterogeneity of lymphangiogenesis in different mouse strains.

Regenfuss B, Onderka J, Bock F, Hos D, Maruyama K, Cursiefen C. Regenfuss B, et al. Among authors: hos d. Am J Pathol. 2010 Jul;177(1):501-10. doi: 10.2353/ajpath.2010.090794. Epub 2010 May 20. Am J Pathol. 2010. PMID: 20489140 Free PMC article.

8

Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.

Hos D, Saban DR, Bock F, Regenfuss B, Onderka J, Masli S, Cursiefen C. Hos D, et al. Arch Ophthalmol. 2011 Apr;129(4):445-52. doi: 10.1001/archophthalmol.2011.42. Arch Ophthalmol. 2011. PMID: 21482870

9

Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.

Hos D, Regenfuss B, Bock F, Onderka J, Cursiefen C. Hos D, et al. Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5778-85. doi: 10.1167/iovs.10-6816. Invest Ophthalmol Vis Sci. 2011. PMID: 21666240

10

Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.

Bock F, Maruyama K, Regenfuss B, Hos D, Steven P, Heindl LM, Cursiefen C. Bock F, et al. Among authors: hos d. Prog Retin Eye Res. 2013 May;34:89-124. doi: 10.1016/j.preteyeres.2013.01.001. Epub 2013 Jan 22. Prog Retin Eye Res. 2013. PMID: 23348581 Review.

11

Split cornea transplantation: relationship between storage time of split donor tissue and outcome.

Heindl LM, Riss S, Adler W, Bucher F, Hos D, Cursiefen C. Heindl LM, et al. Among authors: hos d. Ophthalmology. 2013 May;120(5):899-907. doi: 10.1016/j.ophtha.2012.11.012. Epub 2013 Feb 8. Ophthalmology. 2013. PMID: 23399381

12

[Immune reactions after DMEK, DSAEK and DALK].

Steven P, Hos D, Heindl LM, Bock F, Cursiefen C. Steven P, et al. Among authors: hos d. Klin Monbl Augenheilkd. 2013 May;230(5):494-9. doi: 10.1055/s-0032-1328257. Epub 2013 Feb 27. Klin Monbl Augenheilkd. 2013. PMID: 23446757 Review. German.

13

Retrocorneal membrane formation after Baerveldt shunt implantation for iridocorneal endothelial syndrome.

Bucher F, Dietlein T, Hermann M, Hos D, Cursiefen C, Heindl LM. Bucher F, et al. Among authors: hos d. Cornea. 2013 Jul;32(7):e161-3. doi: 10.1097/ICO.0b013e31828989cd. Cornea. 2013. PMID: 23538633

14

Short- and long-term corneal vascular effects of tafluprost eye drops.

Hos D, Koch KR, Bock F, Grajewski RS, Dietlein TS, Cursiefen C, Heindl LM. Hos D, et al. Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1919-27. doi: 10.1007/s00417-013-2345-0. Epub 2013 Apr 28. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23624591

15

[Anti(lymph)angiogenic preconditioning prior to keratoplasty].

Cursiefen C, Regenfuss B, Hos D, Bucher F, Steven P, Heindl LM, Bock F. Cursiefen C, et al. Among authors: hos d. Klin Monbl Augenheilkd. 2013 May;230(5):500-4. doi: 10.1055/s-0032-1328500. Epub 2013 May 21. Klin Monbl Augenheilkd. 2013. PMID: 23695846 Review. German.

16

Corneal graft alterations after Descemet stripping: implications for split cornea transplantation.

Heindl LM, Riss S, Adler W, Steven P, Hos D, Cursiefen C. Heindl LM, et al. Among authors: hos d. JAMA Ophthalmol. 2013 May;131(5):687-9. doi: 10.1001/jamaophthalmol.2013.794. JAMA Ophthalmol. 2013. PMID: 23699848 No abstract available.

17

Descemet membrane endothelial keratoplasty in eyes with glaucoma implants.

Heindl LM, Koch KR, Bucher F, Hos D, Steven P, Koch HR, Cursiefen C. Heindl LM, et al. Among authors: hos d. Optom Vis Sci. 2013 Sep;90(9):e241-4; discussion 1029. doi: 10.1097/OPX.0b013e31829d8e64. Optom Vis Sci. 2013. PMID: 23892494

18

"OSMO-UT-DSAEK" using THIN-C medium.

Bucher F, Roters S, Mellein A, Hos D, Heindl LM, Cursiefen C, Hermann M. Bucher F, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2181-5. doi: 10.1007/s00417-013-2434-0. Epub 2013 Aug 2. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23907483

19

Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.

Hos D, Koch KR, Bucher F, Bock F, Cursiefen C, Heindl LM. Hos D, et al. Invest Ophthalmol Vis Sci. 2013 Sep 11;54(9):6133-42. doi: 10.1167/iovs.13-12460. Invest Ophthalmol Vis Sci. 2013. PMID: 23970469

20

Lymphatic vessels in the development of tissue and organ rejection.

Hos D, Cursiefen C. Hos D, et al. Adv Anat Embryol Cell Biol. 2014;214:119-41. doi: 10.1007/978-3-7091-1646-3_10. Adv Anat Embryol Cell Biol. 2014. PMID: 24276891 Review.

21

Regression of mature lymphatic vessels in the cornea by photodynamic therapy.

Bucher F, Bi Y, Gehlsen U, Hos D, Cursiefen C, Bock F. Bucher F, et al. Among authors: hos d. Br J Ophthalmol. 2014 Mar;98(3):391-5. doi: 10.1136/bjophthalmol-2013-303887. Epub 2014 Jan 10. Br J Ophthalmol. 2014. PMID: 24414403

22

Evidence of donor corneal endothelial cell migration from immune reactions occurring after descemet membrane endothelial keratoplasty.

Hos D, Heindl LM, Bucher F, Cursiefen C. Hos D, et al. Cornea. 2014 Apr;33(4):331-4. doi: 10.1097/ICO.0000000000000054. Cornea. 2014. PMID: 24488131

23

Autocrine impact of VEGF-A on uveal melanoma cells.

Koch KR, Refaian N, Hos D, Schlereth SL, Bosch JJ, Cursiefen C, Heindl LM. Koch KR, et al. Among authors: hos d. Invest Ophthalmol Vis Sci. 2014 Apr 25;55(4):2697-704. doi: 10.1167/iovs.13-13254. Invest Ophthalmol Vis Sci. 2014. PMID: 24677103

24

Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.

Lipp M, Bucher F, Parthasarathy A, Hos D, Onderka J, Cursiefen C, Bock F. Lipp M, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):943-9. doi: 10.1007/s00417-014-2626-2. Epub 2014 Apr 15. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24728466

25

Corneal nerve alterations in different stages of Fuchs' endothelial corneal dystrophy: an in vivo confocal microscopy study.

Bucher F, Adler W, Lehmann HC, Hos D, Steven P, Cursiefen C, Heindl LM. Bucher F, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2014 Jul;252(7):1119-26. doi: 10.1007/s00417-014-2678-3. Epub 2014 May 30. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24874747

26

Severe vitamin A deficiency in a child presenting as xerophthalmia.

Hos D, Cursiefen C. Hos D, et al. J Pediatr. 2014 Oct;165(4):875. doi: 10.1016/j.jpeds.2014.06.054. Epub 2014 Jul 26. J Pediatr. 2014. PMID: 25074858 No abstract available.

27

Safety of donor tissue preparation and use of descemetoschisis and torn tissue in descemet membrane endothelial keratoplasty.

Heindl LM, Bucher F, Caramoy A, Hos D, Matthaei M, Cursiefen C. Heindl LM, et al. Among authors: hos d. Cornea. 2014 Oct;33(10):e7-9. doi: 10.1097/ICO.0000000000000208. Cornea. 2014. PMID: 25090167 No abstract available.

28

Corneal nerve alterations after Descemet membrane endothelial keratoplasty: an in vivo confocal microscopy study.

Bucher F, Hos D, Matthaei M, Steven P, Cursiefen C, Heindl LM. Bucher F, et al. Among authors: hos d. Cornea. 2014 Nov;33(11):1134-9. doi: 10.1097/ICO.0000000000000250. Cornea. 2014. PMID: 25222002

29

Novel lamellar, flap-based tattooing techniques for corneal opacities in scarred and vascularized blind eyes.

Hos D, Heindl LM, Bucher F, Cursiefen C. Hos D, et al. Cornea. 2015 Jan;34(1):82-6. doi: 10.1097/ICO.0000000000000259. Cornea. 2015. PMID: 25233327

30

[Decellularized collagen matrix from tilapia fish scales for corneal reconstruction (BioCornea)].

Hos D, van Essen TH, Bock F, Chou CH, Pan HA, Lin CC, Huang MC, Chen SC, Cursiefen C, Jager MJ. Hos D, et al. Ophthalmologe. 2014 Nov;111(11):1027-32. doi: 10.1007/s00347-013-3011-y. Ophthalmologe. 2014. PMID: 25337678 Review. German.

31

Antilymphangiogenic therapy to promote transplant survival and to reduce cancer metastasis: what can we learn from the eye?

Hos D, Schlereth SL, Bock F, Heindl LM, Cursiefen C. Hos D, et al. Semin Cell Dev Biol. 2015 Feb;38:117-30. doi: 10.1016/j.semcdb.2014.11.003. Epub 2014 Nov 20. Semin Cell Dev Biol. 2015. PMID: 25460541 Review.

32

Spontaneous long-term course of persistent peripheral graft detachments after Descemet's membrane endothelial keratoplasty.

Bucher F, Hos D, Müller-Schwefe S, Steven P, Cursiefen C, Heindl LM. Bucher F, et al. Among authors: hos d. Br J Ophthalmol. 2015 Jun;99(6):768-72. doi: 10.1136/bjophthalmol-2014-305562. Epub 2014 Dec 19. Br J Ophthalmol. 2015. PMID: 25527695

33

[Prolapse of the upper lacrimal punctum].

Bucher F, Fries JW, Hos D, Koch KR, Cursiefen C, Heindl LM. Bucher F, et al. Among authors: hos d. Ophthalmologe. 2015 Sep;112(9):788-90. doi: 10.1007/s00347-015-0011-0. Ophthalmologe. 2015. PMID: 25930179 German. No abstract available.

34

Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.

Lee HS, Hos D, Blanco T, Bock F, Reyes NJ, Mathew R, Cursiefen C, Dana R, Saban DR. Lee HS, et al. Among authors: hos d. Invest Ophthalmol Vis Sci. 2015 May;56(5):3140-8. doi: 10.1167/iovs.14-16186. Invest Ophthalmol Vis Sci. 2015. PMID: 26024097 Free PMC article.

35

The Naïve Murine Cornea as a Model System to Identify Novel Endogenous Regulators of Lymphangiogenesis: TRAIL and rtPA.

Regenfuß B, Dreisow ML, Hos D, Masli S, Bock F, Cursiefen C. Regenfuß B, et al. Among authors: hos d. Lymphat Res Biol. 2015 Jun;13(2):76-84. doi: 10.1089/lrb.2015.0004. Lymphat Res Biol. 2015. PMID: 26091403 Free PMC article.

36

Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.

Refaian N, Schlereth SL, Koch KR, Notara M, Hos D, Mescher M, Iden S, Bosch JJ, Jager MJ, Cursiefen C, Heindl LM. Refaian N, et al. Among authors: hos d. Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5691-7. doi: 10.1167/iovs.15-16829. Invest Ophthalmol Vis Sci. 2015. PMID: 26313304

37

IL-10 Indirectly Regulates Corneal Lymphangiogenesis and Resolution of Inflammation via Macrophages.

Hos D, Bucher F, Regenfuss B, Dreisow ML, Bock F, Heindl LM, Eming SA, Cursiefen C. Hos D, et al. Am J Pathol. 2016 Jan;186(1):159-71. doi: 10.1016/j.ajpath.2015.09.012. Epub 2015 Nov 20. Am J Pathol. 2016. PMID: 26608451 Free article.

38

Blockade of CCR7 leads to decreased dendritic cell migration to draining lymph nodes and promotes graft survival in low-risk corneal transplantation.

Hos D, Dörrie J, Schaft N, Bock F, Notara M, Kruse FE, Krautwald S, Cursiefen C, Bachmann BO. Hos D, et al. Exp Eye Res. 2016 May;146:1-6. doi: 10.1016/j.exer.2015.12.004. Epub 2015 Dec 12. Exp Eye Res. 2016. PMID: 26689751

39

Advantages of microscope-integrated intraoperative online optical coherence tomography: usage in Boston keratoprosthesis type I surgery.

Siebelmann S, Steven P, Hos D, Hüttmann G, Lankenau E, Bachmann B, Cursiefen C. Siebelmann S, et al. Among authors: hos d. J Biomed Opt. 2016 Jan;21(1):16005. doi: 10.1117/1.JBO.21.1.016005. J Biomed Opt. 2016. PMID: 26780223 Free article. No abstract available.

40

[Boston-keratoprosthesis : Preliminary experiences in 13 high-risk eyes from the Department of Ophthalmology of the University of Cologne].

Schaub F, Hos D, Bucher F, Siebelmann S, Bachmann BO, Cursiefen C. Schaub F, et al. Among authors: hos d. Ophthalmologe. 2016 Jun;113(6):492-9. doi: 10.1007/s00347-015-0209-1. Ophthalmologe. 2016. PMID: 26815458 Clinical Trial. German.

41

Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor.

Bock F, Onderka J, Braun G, Schneider AC, Hos D, Bi Y, Bachmann BO, Cursiefen C. Bock F, et al. Among authors: hos d. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6554-6560. doi: 10.1167/iovs.15-18526. Invest Ophthalmol Vis Sci. 2016. PMID: 27918829

42

Incidence and Clinical Course of Immune Reactions after Descemet Membrane Endothelial Keratoplasty: Retrospective Analysis of 1000 Consecutive Eyes.

Hos D, Tuac O, Schaub F, Stanzel TP, Schrittenlocher S, Hellmich M, Bachmann BO, Cursiefen C. Hos D, et al. Ophthalmology. 2017 Apr;124(4):512-518. doi: 10.1016/j.ophtha.2016.12.017. Epub 2017 Jan 13. Ophthalmology. 2017. PMID: 28094043

43

Wound-Healing Studies in Cornea and Skin: Parallels, Differences and Opportunities.

Bukowiecki A, Hos D, Cursiefen C, Eming SA. Bukowiecki A, et al. Among authors: hos d. Int J Mol Sci. 2017 Jun 12;18(6):1257. doi: 10.3390/ijms18061257. Int J Mol Sci. 2017. PMID: 28604651 Free PMC article. Review.

44

Transient Ingrowth of Lymphatic Vessels into the Physiologically Avascular Cornea Regulates Corneal Edema and Transparency.

Hos D, Bukowiecki A, Horstmann J, Bock F, Bucher F, Heindl LM, Siebelmann S, Steven P, Dana R, Eming SA, Cursiefen C. Hos D, et al. Sci Rep. 2017 Aug 3;7(1):7227. doi: 10.1038/s41598-017-07806-4. Sci Rep. 2017. PMID: 28775329 Free PMC article.

45

Evolution of Consecutive Descemet Membrane Endothelial Keratoplasty Outcomes Throughout a 5-Year Period Performed by Two Experienced Surgeons.

Schrittenlocher S, Schaub F, Hos D, Siebelmann S, Cursiefen C, Bachmann B. Schrittenlocher S, et al. Among authors: hos d. Am J Ophthalmol. 2018 Jun;190:171-178. doi: 10.1016/j.ajo.2018.03.036. Epub 2018 Apr 3. Am J Ophthalmol. 2018. PMID: 29621512

46

Detection of Pro- and Antiangiogenic Factors in the Human Sclera.

Schlereth SL, Karlstetter M, Hos D, Matthaei M, Cursiefen C, Heindl LM. Schlereth SL, et al. Among authors: hos d. Curr Eye Res. 2019 Feb;44(2):172-184. doi: 10.1080/02713683.2018.1540704. Epub 2018 Nov 9. Curr Eye Res. 2019. PMID: 30358460

47

[10 years of Descemet membrane endothelial keratoplasty in Fuchs endothelial corneal dystrophy : What have we learned?].

Matthaei M, Schrittenlocher S, Hos D, Siebelmann S, Bucher F, Schaub F, Hoerster R, Siggel R, Roters S, Heindl LM, Bachmann B, Cursiefen C. Matthaei M, et al. Among authors: hos d. Ophthalmologe. 2019 Mar;116(3):236-242. doi: 10.1007/s00347-018-0800-3. Ophthalmologe. 2019. PMID: 30367230 Review. German.

48

[Boston type I keratoprosthesis implantation technique : Video article].

Matthaei M, Bachmann B, Hos D, Siebelmann S, Schaub F, Cursiefen C. Matthaei M, et al. Among authors: hos d. Ophthalmologe. 2019 Jan;116(1):67-72. doi: 10.1007/s00347-018-0806-x. Ophthalmologe. 2019. PMID: 30367233 Review. German.

49

Phase-specific functions of macrophages determine injury-mediated corneal hem- and lymphangiogenesis.

Kiesewetter A, Cursiefen C, Eming SA, Hos D. Kiesewetter A, et al. Among authors: hos d. Sci Rep. 2019 Jan 22;9(1):308. doi: 10.1038/s41598-018-36526-6. Sci Rep. 2019. PMID: 30670724 Free PMC article.

50

Von Hippel Lindau Disease.

Hos D, Cursiefen C, Dahlke C. Hos D, et al. J Pediatr. 2019 Jun;209:252. doi: 10.1016/j.jpeds.2019.01.053. Epub 2019 Mar 8. J Pediatr. 2019. PMID: 30853203 No abstract available.

51

Does anterior chamber-associated immune deviation (ACAID) play a role in posterior lamellar keratoplasty? Case report of a splenectomized patient.

Hos D, Schaub F, Cursiefen C. Hos D, et al. BMC Ophthalmol. 2019 May 2;19(1):100. doi: 10.1186/s12886-019-1114-1. BMC Ophthalmol. 2019. PMID: 31046736 Free PMC article.

52

Midterm follow-up of immune reactions after Descemet membrane endothelial keratoplasty (DMEK).

Schaub F, Bachmann BO, Cursiefen C, Hos D. Schaub F, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1811-1812. doi: 10.1007/s00417-019-04357-4. Epub 2019 May 18. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31104139 No abstract available.

53

Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study.

Hos D, Le VNH, Hellmich M, Siebelmann S, Roters S, Bachmann BO, Cursiefen C. Hos D, et al. Transplant Direct. 2019 Apr 25;5(5):e452. doi: 10.1097/TXD.0000000000000894. eCollection 2019 May. Transplant Direct. 2019. PMID: 31165087 Free PMC article.

54

Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.

Hos D, Matthaei M, Bock F, Maruyama K, Notara M, Clahsen T, Hou Y, Le VNH, Salabarria AC, Horstmann J, Bachmann BO, Cursiefen C. Hos D, et al. Prog Retin Eye Res. 2019 Nov;73:100768. doi: 10.1016/j.preteyeres.2019.07.001. Epub 2019 Jul 3. Prog Retin Eye Res. 2019. PMID: 31279005 Free article. Review.

55

Outcome of Descemet Membrane Endothelial Keratoplasty Using Corneas from Donors ≥80 Years of Age.

Schaub F, Collmer M, Schrittenlocher S, Bachmann BO, Cursiefen C, Hos D. Schaub F, et al. Among authors: hos d. Am J Ophthalmol. 2020 Mar;211:200-206. doi: 10.1016/j.ajo.2019.12.001. Epub 2019 Dec 16. Am J Ophthalmol. 2020. PMID: 31837315

56

Effect of Iris Color on the Outcome of Descemet Membrane Endothelial Keratoplasty.

Hayashi T, Hos D, Schrittenlocher S, Siebelmann S, Matthaei M, Franklin J, Clahsen T, Bock F, Bachmann B, Cursiefen C. Hayashi T, et al. Among authors: hos d. Cornea. 2020 Jul;39(7):846-850. doi: 10.1097/ICO.0000000000002305. Cornea. 2020. PMID: 32195753

57

Topical VEGF-C/D Inhibition Prevents Lymphatic Vessel Ingrowth into Cornea but Does Not Improve Corneal Graft Survival.

Salabarria AC, Koch M, Schönberg A, Zinser E, Hos D, Hamdorf M, Imhof T, Braun G, Cursiefen C, Bock F. Salabarria AC, et al. Among authors: hos d. J Clin Med. 2020 Apr 28;9(5):1270. doi: 10.3390/jcm9051270. J Clin Med. 2020. PMID: 32353986 Free PMC article.

58

New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting.

Schlereth SL, Hos D, Matthaei M, Hamrah P, Schmetterer L, O'Leary O, Ullmer C, Horstmann J, Bock F, Wacker K, Schröder H, Notara M, Haagdorens M, Nuijts RMMA, Dunker SL, Dickman MM, Fauser S, Scholl HPN, Wheeler-Schilling T, Cursiefen C. Schlereth SL, et al. Among authors: hos d. Ophthalmic Res. 2021;64(2):145-167. doi: 10.1159/000509954. Epub 2020 Jul 7. Ophthalmic Res. 2021. PMID: 32634808 Free article. Review.

59

VEGF Trap_R1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis.

Le VNH, Hos D, Hou Y, Witt M, Barkovskiy M, Bock F, Cursiefen C. Le VNH, et al. Among authors: hos d. Transl Vis Sci Technol. 2020 Oct 14;9(11):15. doi: 10.1167/tvst.9.11.15. eCollection 2020 Oct. Transl Vis Sci Technol. 2020. PMID: 33117607 Free PMC article.

60

Descemet Membrane Endothelial Keratoplasty in Vascularized Eyes: Outcome and Effect on Corneal Neovascularization.

Hayashi T, Zhang W, Hos D, Schrittenlocher S, Nhat Hung Le V, Siebelmann S, Matthaei M, Bock F, Bachmann B, Cursiefen C. Hayashi T, et al. Among authors: hos d. Cornea. 2021 Jun 1;40(6):685-689. doi: 10.1097/ICO.0000000000002502. Cornea. 2021. PMID: 33252385

61

Corneal Crosslinking to Regress Pathologic Corneal Neovascularization Before High-Risk Keratoplasty.

Schaub F, Hou Y, Zhang W, Bock F, Hos D, Cursiefen C. Schaub F, et al. Among authors: hos d. Cornea. 2021 Feb 1;40(2):147-155. doi: 10.1097/ICO.0000000000002406. Cornea. 2021. PMID: 33395116

62

[Treatment of vascularized high-risk eyes with a Boston keratoprosthesis].

Schaub F, Matthaei M, Enders P, Siebelmann S, Hos D, Bachmann BO, Cursiefen C. Schaub F, et al. Among authors: hos d. Ophthalmologe. 2021 Jun;118(6):544-552. doi: 10.1007/s00347-021-01356-x. Epub 2021 Mar 17. Ophthalmologe. 2021. PMID: 33730307 Review. German.

63

[Descemet membrane endothelial keratoplasty (DMEK) for graft failure after penetrating keratoplasty and in vascularized high-risk eyes].

Hos D, Schlereth S, Schrittenlocher S, Hayashi T, Bock F, Matthaei M, Bachmann BO, Cursiefen C. Hos D, et al. Ophthalmologe. 2021 Jun;118(6):536-543. doi: 10.1007/s00347-021-01384-7. Epub 2021 Apr 16. Ophthalmologe. 2021. PMID: 33860823 Review. German.

64

Macrophage-Mediated Tissue Vascularization: Similarities and Differences Between Cornea and Skin.

Hadrian K, Willenborg S, Bock F, Cursiefen C, Eming SA, Hos D. Hadrian K, et al. Among authors: hos d. Front Immunol. 2021 Apr 7;12:667830. doi: 10.3389/fimmu.2021.667830. eCollection 2021. Front Immunol. 2021. PMID: 33897716 Free PMC article. Review.

65

Comparison of Mini-DMEK versus predescemetal sutures as treatment of acute hydrops in keratoconus.

Händel A, Siebelmann S, Hos D, Ögrünc F, Matthaei M, Cursiefen C, Bachmann B. Händel A, et al. Among authors: hos d. Acta Ophthalmol. 2021 Dec;99(8):e1326-e1333. doi: 10.1111/aos.14835. Epub 2021 May 4. Acta Ophthalmol. 2021. PMID: 33942986 Free article.

66

[Preconditioning of vascularized high-risk eyes using fine-needle diathermy and cross-linking].

Matthaei M, Hos D, Bock F, Le VNH, Hou Y, Schaub F, Siebelmann S, Zhang W, Roters S, Bachmann BO, Cursiefen C. Matthaei M, et al. Among authors: hos d. Ophthalmologe. 2021 Jun;118(6):553-560. doi: 10.1007/s00347-021-01415-3. Epub 2021 May 7. Ophthalmologe. 2021. PMID: 33961088 Review. German.

67

Cutting Edge: Novel Treatment Options Targeting Corneal Neovascularization to Improve High-Risk Corneal Graft Survival.

Cursiefen C, Hos D. Cursiefen C, et al. Among authors: hos d. Cornea. 2021 Dec 1;40(12):1512-1518. doi: 10.1097/ICO.0000000000002736. Cornea. 2021. PMID: 34116541 Review.

68

Lymphatic Trafficking in the Eye: Modulation of Lymphatic Trafficking to Promote Corneal Transplant Survival.

Hou Y, Bock F, Hos D, Cursiefen C. Hou Y, et al. Among authors: hos d. Cells. 2021 Jul 2;10(7):1661. doi: 10.3390/cells10071661. Cells. 2021. PMID: 34359831 Free PMC article. Review.

69

Three-year follow-up of high-risk keratoplasty following fine-needle diathermy of corneal neovascularization combined with bevacizumab.

Mestanoglu M, Händel A, Cursiefen C, Hos D. Mestanoglu M, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2383-2385. doi: 10.1007/s00417-021-05546-w. Epub 2022 Jan 6. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34989865 Free PMC article. No abstract available.

70

Outcomes of deep anterior lamellar keratoplasty and penetrating keratoplasty in keratoconic eyes with and without previous hydrops.

Händel A, Lüke JN, Siebelmann S, Franklin J, Roters S, Matthaei M, Bachmann BO, Cursiefen C, Hos D. Händel A, et al. Among authors: hos d. Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2913-2923. doi: 10.1007/s00417-022-05643-4. Epub 2022 Apr 7. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35389058

71

Different Murine High-Risk Corneal Transplant Settings Vary Significantly in Their (Lymph)angiogenic and Inflammatory Cell Signatures.

Zhang W, Schönberg A, Bassett F, Hadrian K, Hos D, Becker M, Bock F, Cursiefen C. Zhang W, et al. Among authors: hos d. Invest Ophthalmol Vis Sci. 2022 Dec 1;63(13):18. doi: 10.1167/iovs.63.13.18. Invest Ophthalmol Vis Sci. 2022. PMID: 36534386 Free PMC article.

72

The novel role of lymphatic vessels in the pathogenesis of ocular diseases.

Clahsen T, Hadrian K, Notara M, Schlereth SL, Howaldt A, Prokosch V, Volatier T, Hos D, Schroedl F, Kaser-Eichberger A, Heindl LM, Steven P, Bosch JJ, Steinkasserer A, Rokohl AC, Liu H, Mestanoglu M, Kashkar H, Schumacher B, Kiefer F, Schulte-Merker S, Matthaei M, Hou Y, Fassbender S, Jantsch J, Zhang W, Enders P, Bachmann B, Bock F, Cursiefen C. Clahsen T, et al. Among authors: hos d. Prog Retin Eye Res. 2023 Sep;96:101157. doi: 10.1016/j.preteyeres.2022.101157. Epub 2023 Feb 8. Prog Retin Eye Res. 2023. PMID: 36759312 Review.

73

The role of the osmosensitive transcription factor NFAT5 in corneal edema resorption after injury.

Hadrian K, Musial G, Schönberg A, Georgiev T, Küper C, Bock F, Jantsch J, Cursiefen C, Eming SA, Hos D. Hadrian K, et al. Among authors: hos d. Exp Mol Med. 2023 Mar;55(3):565-573. doi: 10.1038/s12276-023-00954-w. Epub 2023 Mar 3. Exp Mol Med. 2023. PMID: 36869067 Free PMC article.

74

UV light-mediated corneal crosslinking as (lymph)angioregressive pretreatment to promote graft survival after subsequent high-risk corneal transplantation (CrossCornealVision): protocol for a multicenter, randomized controlled trial.

Wiedemann J, Hos D, Limburg E, Zettelmeyer U, Schiller P, Franklin J, Bachmann B, Böhringer D, Dietrich-Ntoukas T, Fuchsluger TA, Geerling G, Lang SJ, Mayer WJ, Priglinger S, Reinhard T, Seitz B, Cursiefen C. Wiedemann J, et al. Among authors: hos d. Trials. 2024 Mar 6;25(1):169. doi: 10.1186/s13063-024-08011-1. Trials. 2024. PMID: 38448965 Free PMC article.

75

[Topical inhibition of angiogenesis at the cornea. Safety and efficacy].

Regenfuss B, Bock F, Bachmann B, König Y, Hos D, Parthasarathy A, Cursiefen C. Regenfuss B, et al. Among authors: hos d. Ophthalmologe. 2009 May;106(5):399-406. doi: 10.1007/s00347-009-1934-0. Ophthalmologe. 2009. PMID: 19396447 Review. German.

76

[New Therapeutic Approaches in Inflammatory Diseases of the Eye - Targeting Lymphangiogenesis and Cellular Immunity: Research Unit FOR 2240 Presents Itself].

Cursiefen C, Bock F, Clahsen T, Regenfuss B, Reis A, Steven P, Heindl LM, Bosch JJ, Hos D, Eming S, Grajewski R, Heiligenhaus A, Fauser S, Austin J, Langmann T. Cursiefen C, et al. Among authors: hos d. Klin Monbl Augenheilkd. 2017 May;234(5):679-685. doi: 10.1055/s-0043-108247. Epub 2017 May 15. Klin Monbl Augenheilkd. 2017. PMID: 28505676 Review. German.

77

[The situation of residents in ophthalmology in Germany: Results of an online survey].

Hos D, Steven P, Dietrich-Ntoukas T. Hos D, et al. Ophthalmologe. 2015 Jun;112(6):498-503. doi: 10.1007/s00347-015-0030-x. Ophthalmologe. 2015. PMID: 26014052 German.

78

Errata: Advantages of microscope-integrated intraoperative online optical coherence tomography: usage in Boston keratoprosthesis type I surgery.

Siebelmann S, Steven P, Hos D, Hüttmann G, Lankenau E, Bachmann B, Cursiefena C. Siebelmann S, et al. Among authors: hos d. J Biomed Opt. 2016 Feb;21(2):29801. doi: 10.1117/1.JBO.21.2.029801. J Biomed Opt. 2016. PMID: 26836211 Free article. No abstract available.

79

[Research during residency].

Prokosch-Willing V, Hos D, Joachim SC. Prokosch-Willing V, et al. Among authors: hos d. Ophthalmologe. 2017 Oct;114(10):901-905. doi: 10.1007/s00347-017-0566-z. Ophthalmologe. 2017. PMID: 28956127 Review. German.

80

TRIM21 Is Targeted for Chaperone-Mediated Autophagy during Salmonella Typhimurium Infection.

Hos NJ, Fischer J, Hos D, Hejazi Z, Calabrese C, Ganesan R, Murthy AMV, Rybniker J, Kumar S, Krönke M, Robinson N. Hos NJ, et al. Among authors: hos d. J Immunol. 2020 Nov 1;205(9):2456-2467. doi: 10.4049/jimmunol.2000048. Epub 2020 Sep 18. J Immunol. 2020. PMID: 32948684 Free PMC article.

81

Type I interferon enhances necroptosis of Salmonella Typhimurium-infected macrophages by impairing antioxidative stress responses.

Hos NJ, Ganesan R, Gutiérrez S, Hos D, Klimek J, Abdullah Z, Krönke M, Robinson N. Hos NJ, et al. Among authors: hos d. J Cell Biol. 2017 Dec 4;216(12):4107-4121. doi: 10.1083/jcb.201701107. Epub 2017 Oct 20. J Cell Biol. 2017. PMID: 29055012 Free PMC article.

82

Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes.

Hoffmann SA, Hos D, Küspert M, Lang RA, Lovell-Badge R, Wegner M, Reiprich S. Hoffmann SA, et al. Among authors: hos d. Development. 2014 Jan;141(1):39-50. doi: 10.1242/dev.098418. Epub 2013 Nov 20. Development. 2014. PMID: 24257626 Free PMC article.

83

P62 inhibits IL-1β release during Salmonella Typhimurium infection of macrophages.

Hos NJ, Fischer J, Murthy AMV, Hejazi Z, Krönke M, Hos D, Robinson N. Hos NJ, et al. Among authors: hos d. Front Cell Infect Microbiol. 2025 Apr 10;15:1495567. doi: 10.3389/fcimb.2025.1495567. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40276384 Free PMC article.

84

Corrigendum: Macrophage variants in laboratory research: most are well done, but some are RAW.

Herb M, Schatz V, Hadrian K, Hos D, Holoborodko B, Jantsch J, Brigo N. Herb M, et al. Among authors: hos d. Front Cell Infect Microbiol. 2025 Feb 26;15:1575550. doi: 10.3389/fcimb.2025.1575550. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40078877 Free PMC article.

85

Corneal Endothelial Keratoprosthesis EndoArt in Patients With Glaucoma at High Risk of Graft Failure After Keratoplasty.

Wiedemann J, Hos D, Mestanoglu M, Cursiefen C, Bachmann B. Wiedemann J, et al. Among authors: hos d. Cornea. 2024 Oct 29;44(5):559-566. doi: 10.1097/ICO.0000000000003709. Cornea. 2024. PMID: 39499171

86

Macrophage variants in laboratory research: most are well done, but some are RAW.

Herb M, Schatz V, Hadrian K, Hos D, Holoborodko B, Jantsch J, Brigo N. Herb M, et al. Among authors: hos d. Front Cell Infect Microbiol. 2024 Oct 9;14:1457323. doi: 10.3389/fcimb.2024.1457323. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39445217 Free PMC article. Review.

87

Selective, Temporary Postoperative Inhibition of Lymphangiogenesis by Integrin α5β1 Blockade Improves Allograft Survival in a Murine Model of High-Risk Corneal Transplantation.

Dietrich-Ntoukas T, Bock F, Onderka J, Hos D, Bachmann BO, Zahn G, Cursiefen C. Dietrich-Ntoukas T, et al. Among authors: hos d. J Clin Med. 2024 Jul 28;13(15):4418. doi: 10.3390/jcm13154418. J Clin Med. 2024. PMID: 39124685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters